-
Y0001038
BENAZEPRIL FOR SYSTEM SUITABILITY EUROPEAN PHARMACOPOEIA (EP) REFERENCE STANDARD
Price: $415.60List Price: $461.78General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the -
B334933-250mg
Benazepril Free base
Price: $400.56List Price: $445.06Benazepril Free base is an inhibitor of ACE (angiotensin-converting enzyme). This blocks the conversion of angiotensin I to angiotensin II, which in turn prevents vasoconstriction associated with activation of angiotensin II receptors. -
Y0001026
BENAZEPRIL IMPURITY A EUROPEAN PHARMACOPOEIA (EP) REFERENCE STANDARD
Price: $341.11List Price: $379.01General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the -
1048620-25MG
BENAZEPRIL RELATED COMPOUND A UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,661.34List Price: $2,957.04This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1048630-15MG
BENAZEPRIL RELATED COMPOUND B UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,661.34List Price: $2,957.04This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1048641-50MG
BENAZEPRIL RELATED COMPOUND C UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,481.52List Price: $2,757.24This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1048652-15MG
BENAZEPRIL RELATED COMPOUND D UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,607.39List Price: $2,897.10This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1048663-25MG
BENAZEPRIL RELATED COMPOUND E UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,607.39List Price: $2,897.10This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
B334932-5mg
Benazeprilat (C007B-064707)
Price: $304.93List Price: $338.81Benazeprilat is the active metabolite of benazepril , formed after cleavage of the ester group. Benazeprilat is a potent inhibitor of angiotensin-converting enzyme (ACE). This prevents the conversion of angiotensin I to the vasoconstrictor -
B334932-100mg
Benazeprilat (C007B-438686)
Price: $1,130.96List Price: $1,256.62Benazeprilat is the active metabolite of benazepril , formed after cleavage of the ester group. Benazeprilat is a potent inhibitor of angiotensin-converting enzyme (ACE). This prevents the conversion of angiotensin I to the vasoconstrictor -
B334932-10mg
Benazeprilat (C007B-438687)
Price: $355.32List Price: $394.80Benazeprilat is the active metabolite of benazepril , formed after cleavage of the ester group. Benazeprilat is a potent inhibitor of angiotensin-converting enzyme (ACE). This prevents the conversion of angiotensin I to the vasoconstrictor -
B334932-25mg
Benazeprilat (C007B-438688)
Price: $583.66List Price: $648.51Benazeprilat is the active metabolite of benazepril , formed after cleavage of the ester group. Benazeprilat is a potent inhibitor of angiotensin-converting enzyme (ACE). This prevents the conversion of angiotensin I to the vasoconstrictor